Details
Bicalutamid Indications
Prostate cancer (late stages) in combination with therapy analogues of the luteinizing hormone releasing factor or surgical castration.
Monotherapy or adjuvant therapy for radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk of progression of the disease.
Treatment of patients with locally advanced, non-metastatic prostate cancer, for which surgical castration or other medical interventions are not indicated or unacceptable.
Contradictions
Women and children
Patients who experienced hypersensitivity reactions to the active substance or to any of the excipients included in the drug
Concomitant use of BICALUTAMID with terfenadine, astemizole or cisapride is contraindicated.
Dosage & Administration
Monotherapy or adjuvant therapy for radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk of progression of the disease.
Treatment of patients with locally advanced, non-metastatic prostate cancer, for which surgical castration or other medical interventions are not indicated or unacceptable.
